Sam E. Khan Counsel

New Jersey
T 973.597.6372 | F 973.597.6373



Practicing corporate law keeps Sam Khan striving to be the first and only call his clients make when facing complex transactional work. Sam enjoys working closely with a wide variety of clients, ranging from financial institutions and hedge funds to pharmaceutical companies and global manufacturers to clients in the media and entertainment space, with the goal of fashioning innovative legal solutions. He provides an extensive array of corporate legal services with special emphasis on leveraged finance representing both borrowers and lenders, buy- and sell-side public and private mergers and acquisitions, joint ventures and asset dispositions, as well as general corporate finance including matters involving refinancing, restructuring, securities offerings and private investments. 

Prior to joining the firm, Sam was an associate at Sullivan & Cromwell LLP, New York, where he handled a broad range of matters in both the corporate finance and mergers and acquisitions groups.

Representative Engagements

Represented Medical Specialties Distributors, LLC, a New Mountain Capital portfolio company, in its acquisition of First Choice Medical Holdings, Inc.

Press Mentions

Lowenstein Sandler represented Matawan Pharmaceuticals LLC in the sale of Retin-A® (tretinoin) to Perrigo Company plc (“Perrigo”) (NYSE: PRGO; TASE). Generic and brand sales of Retin-A®, a topical treatment for acne vulgaris, were valued at approximately $290 million for the 12-month period ending November 2015. The Lowenstein deal team was led by Michael Lerner and included Nick Mehler, Sam KhanNick Samedi and Robert Bee. , January 25, 2016
Lowenstein Sandler is representing long-time client, Indorama Ventures Public Company Limited, in the proposed acquisition of a Decatur, Alabama manufacturing facility from BP Amoco Chemical Company. The definitive purchase agreement for the 1,000-acre, 450-employee facility was signed on January 6, 2016. The acquisition of the Decatur facility is the sixth investment in North America in which Lowenstein represented Indorama and the second in the past year. In 2007, Lowenstein represented Indorama in acquiring the land rights and raw material supply agreement from BP to build its AlphaPet plant, which is co-located at the Decatur site. The Lowenstein team was led by partner Nicholas San Filippo IV, and included Nicholas Mehler, Christine Osvald-Mruz, Brian Silikovitz, Norman Spindel, Stuart Yusem, Samiul Khan, Ethan Skerry, Lesley Pruzansky Adamo, Eugene Cheval, Robert Bee, and Meredith Jewitt. , January 6, 2016
Lowenstein Sandler represented Metalico, Inc. (NYSE MKT: MEA), one of the nation’s largest scrap metal recyclers, in its execution of the merger agreement for the $102 million all-cash sale to Total Merchant Limited, an investment vehicle formed to seek appropriate opportunities in the United States metals and commodities market. The Lowenstein deal team included Steven M. Skolnick, Alan Wovsaniker, Sam E. KhanNick Samedi and Brian Shemesh. , September 11, 2015
View More...

Related Areas

Capital Markets & Securities
Corporate
Debt Finance
Mergers & Acquisitions
Private Equity
Transactions & Advisory Group

Education


Harvard Law School ( J.D. , 2009 )
University of Texas at Austin ( B.A. , 2005 ) , Phi Beta Kappa, Summa Cum Laude, Triple Major in Philosophy, History, and Arabic Language and Literature

Bar Admissions


New York
New Jersey